Navigation Links
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Date:9/2/2008

tical chemistry. Dr. LaBarre received his BS degree in Chemistry from Southampton College and his PhD in Bioinorganic Chemistry from the University of Arizona.

James E. Cartoni will oversee various legal matters, including the negotiation and completion of agreements, corporate governance matters, securities compliance, and the coordination and management of outside legal counsel. Prior to joining Halozyme, Mr. Cartoni was a partner at DLA Piper, the world's largest law firm, where he represented numerous public and private companies in areas such as financing transactions, corporate compliance, mergers & acquisitions and general business matters. DLA Piper is Halozyme's primary outside corporate counsel and Mr. Cartoni has represented Halozyme since 2004. Mr. Cartoni also served as the Co-Chair of the Legal and Finance Committee for the 2008 U.S. Open at Torrey Pines Golf Course. Mr. Cartoni obtained his BA degree in Political Science from Occidental College and his Juris Doctor degree from the University of California -- Hastings College of the Law in 1998.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the drug delivery, metabolism, oncology, and dermatology markets. The company's portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cumulase(R), for use in in-vitro fertilization, and HYLENEX, for use as an adjuvant
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
2. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
3. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
4. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
5. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
6. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
7. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
8. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
9. Halozyme Therapeutics Amends Stockholder Rights Plan
10. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
11. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... New York (PRWEB) December 23, 2014 According ... the Long Island Affiliate of ITRA Global, the national office ... but steady recovery. This is evidenced by the third ... strong stock market. Low energy costs have held inflation ... The only negative is the housing market remaining soft. , ...
(Date:12/24/2014)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China ... plasma-based biopharmaceutical company in China ... Taibang Biological Products Co. Ltd., has received Good ... and Drug Administration (the "CFDA") for its new ... the Company,s public filings, the CFDA inspected this ...
(Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
(Date:12/22/2014)... SAN DIEGO , Dec. 22, 2014 ... that the Decipher Prostate Cancer Classifier, a genomic test ... disease in node-negative, high-risk men managed by radical prostatectomy ... with radical prostatectomy is relatively uncommon, using tumor genomics ... form of metastatic disease is an important advance. The ...
Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3
... , , , , , Multiporator / Electroporator 2510 , , , ... Transformation Protocol , Protocol No. 4308 915.506 12/2001 , ... , , , , , ... , Cell type , ...
... , Multiporator / Electroporator 2510 , , , , , , ... , Protocol No. 4308 915.503 04/2002 ... , , , , , , , ... , , Cell type , ...
... , , Multiporator / Electroporator 2510 , , , , , , ... Transformation Protocol , Protocol No. 4308 915.501 04/2002 , , ... , , Microorganism , ... Cell type , Bacteria, gram negative, ...
Cached Biology Technology:Borrelia burgdorferi 2Azotobacter vinelandii 2Actinomyces viscosus 2
(Date:12/17/2014)... Dec. 15, 2014 Research and Markets ... of the "Samsung Galaxy S5 - Home ... to their offering. ... different sensing technology than the iPhone 5S, Samsung ... in its product. The Galaxy S5 ...
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today ... audit to confirm its adherence to current U.S. ... enables HITLAB to conduct regulated smart device and ... for patient safety and research quality. ... quality, and delivery with innovative technology," said ...
(Date:12/17/2014)... 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend ... for medical sensors in biomedical applications. Chemical sensors ... and correct diagnosis during surgical procedures. The Global ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... of Florida College of Pharmacy researchers have discovered a ... inhibits cancer cell growth in laboratory tests, a finding ... to better battle the disease. The UF-patented compound, ... reefs. Researchers, who described results from early studies today ...
... efforts may do it more for themselves than the ... Alberta case study shows. A study of purple ... their landrevealed that they were more motivated to take ... altruistic reasons. "Though there were areas of overlap, ...
... international team of researchers has identified just 200 positions ... believe capture much of the genetic diversity in European ... and complex historic origins on Earth. Their findings narrow ... single nucleotide polymorphisms, or SNPs, that cause disease and ...
Cached Biology News:Researchers find cancer-inhibiting compound under the sea 2Researchers find cancer-inhibiting compound under the sea 3For the birds or for me? Why do conservationists really help wildlife? 2Study helps pinpoint genetic variations in European Americans 2Study helps pinpoint genetic variations in European Americans 3
... Analysis Kit is an ultra-sensitive chemiluminescent ... Biochain. It detects protein at attogram ... (10 -24 M) levels. This ... Enhancer, protein interaction system and detection ...
... bioinformatics software that has changed the way ... design of BioNumerics allows for integration and ... data employed for the characterization of organisms ... protein gels, HPLC, VNTR, MLST, SNP, fatty ...
... Since the early 80s Biosearch Technologies ... advanced oligonucleotide tools to accelerate the ... Whether you need dual-labeled FRET probes ... custom oligos for microarray applications, Biosearch ...
UNIVERSAL SCORECARD DNA, 1 EA. * Category: Reagents/Consumables....
Biology Products: